Hypertensive nephrosclerosis: Update

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 2, 2004, Pages 147-154

  Luft, Friedrich C ^a,b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b Wiltbergstrasse 50   (Germany)

Author keywords

Angiotensin 1 receptor blockers; Angiotensin converting enzyme inhibitors; Hypertension; Nephrosclerosis; Renal disease progression

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLONIDINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; FUROSEMIDE; METOPROLOL; MINOXIDIL; PLACEBO; RAMIPRIL; SMAD7 PROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ANIMAL EXPERIMENT; AUTOPSY; CLINICAL TRIAL; DISEASE COURSE; GLOMERULUS; HUMAN; HYPERTENSION; IMMUNITY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; META ANALYSIS; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; REVIEW; STRESS; TRAFFIC ACCIDENT; URETER OBSTRUCTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CYTOKINES; ENVIRONMENT; HUMANS; HYPERTENSION; IMMUNITY; NEPHRONS; NEPHROSCLEROSIS; OXIDATIVE STRESS; PRACTICE GUIDELINES;

EID: 1642360850     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200403000-00002     Document Type: Review

References (33)

1. Wright JT Jr, Bakris G, Greene T, et al., and the African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288:2421-2431. A major clinical trial addressing the issue of nephrosclerosis in African-Americans and how the condition is to be best treated.
2. Reis SE, Olson MB, Fried L, et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002; 105:2826-2829.
3. Toto RB. Hypertensive nephrosclerosis in African Americans. Kidney Int. 2003 Dec;64(6):2331-2341.
4. Vikse BE, Aasarod K, Bostad L, Iversen BM. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant 2003; 18:517-523.
5. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. An exercise in punditry that belongs in everybody's collection!
6. Jafar TH, Stark PC, Schmid CH, et al., for the AIPRD study group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin converting enzyme inhibition. Ann Intern Med 2003; 139:244-252. A large meta-analysis that addresses highly important questions, namely the degree of blood pressure reduction and the impact of proteinuria in chronic renal disease patients without diabetes mellitus.
7. Mulrow CD, Townsend RR. Guiding lights for antihypertensive treatment in patients with nondiabetic renal disease: proteinuria and blood pressure levels? Ann Intern Med 2003; 139:296-299. A thoughtful editorial and commentary on the problems we face in hypertensive patients with decreased renal function.
8. Hoy WE, Wang Z, Baker PRA, Kelly AM. Secondary prevention of renal and cardiovascular disease: results of a renal and cardiovascular treatment program in an Australian aboriginal community. J Am Soc Nephrol 2003; 14:S178-S185.
9. Luft FC. Baa, Baa, black sheep, are your kidneys full? J Physiol 2003; 549:665.
10. Brenner BM, Chertow GM. Congenital oligonephropathy: an inborn cause of adult hypertension and progressive renal injury? Curr Opin Nephrol Hypertens. 1993 Sep;2(5):691-695. Review.
11. Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993 Apr 10;341(8850):938-41.
12. Wintour EM, Moritz KM, Johnson K, et al. Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J Physiol 2003; 549:929-935. An interesting study addressing the issue of nephron number and subsequent blood pressure values.
13. Keller G, Zimmer G, Mall G, et al. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348:101-108. Possibly a landmark study on the issue of nephron number and the development of hypertension in humans.
14. Moritz KM, Johnson K, Douglas-Denton R, et al. Maternal glucocorticoid treatment programs alterations in the rennin-angiotensin system of the ovine fetal kidney. Endocrinology 2002; 143:445-4463.
15. Manning J, Beutler K, Knepper MA, Vehaskari VM. Upregulation of renal BSCI and TSC in prenatally-programmed hypertension. Am J Physiol 2002; 283:F202-F206.
16. Hoy WE, Douglas-Denton RN, Hughson MD, et al. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003; 83:S31-S37. This paper is an important source for data on human glomerular number and size.
17. Razzaque MS, Azouz A, Shinagawa T, Taguchi T. Factors regulating the progression of hypertensive nephrosclerosis. Contrib Nephrol 2003; 139:173-186.
18. Marcantoni C, Ma LJ, Federspiel C, Fogo AB. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 2002; 62:172-180. The paper is an important source of information and should be compared with the findings of Hoy et al. [16•].
19. Schmid H, Cohen CD, Henger A, et al. Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies. Kidney Int 2003; 64:356-360.
20. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183-1190. This paper is a comprehensive review of a potentially very important issue.
21. Müller DN, Shagdarsuren E, Dechend R, et al. Immunosuppressive, anti-inflammatory treatment ameliorates angiotensin II-induced renal damage. Am J Pathol 2002; 161:1679-1693.
22. Tostes RC, Touyz RM, He G, et al. Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension. Clin Sci (Lond) 2002; 103 (Suppl. 48):25S-30S.
23. Mervaala E, Finckenberg P, Lapatto R, et al. Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 2003; 64:501-508.
24. Ying WZ, Sanders PW. The Inter-relationship between TGF-{beta}1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol 2003; 285(5):F902-8. Epub AQ9 (added)
25. Lan HY, Mu W, Tomita N, et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14:1535-1548. There are several novel aspects in this report. The idea of capitalizing on Smad7, the TGF-β inhibitory Smad is an interesting idea. The delivery system would certainly have applicability in man.
26. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700.
27. Finckenberg P, Inkinen K, Ahonen J, et al. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 2003; 163:355-366.
28. 2 production on the development of nephrosclerosis might not have been predicted, although an increase in blood pressure comes as less of a surprise.
29. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346:913-923.
30. Sanders PW, Wang PX. Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats. BMC Nephrol 2002; 3:1.
31. Titze J, Krause H, Hecht H, et al. Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol 2002; 283:F134-F141. This study expresses novel ideas in terms of chronic salt balance.
32. Titze J, Lang R, Ilies C, et al. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol 2003 Dec;285(6):F1108-F1117. In this study perhaps the non-osmotic sodium chloride storage bin has been identified.
33. Stier CT Jr, Chander PN, Rosenfeld L, Powers CA. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 2003; 285:E232-E239.